Valproate, obesity and other causes of clozapine poor metabolism in the context of rapid titration may explain clozapine-induced myocarditis: A re-analysis of a Turkish case series
- 10 December 2022
- journal article
- research article
- Published by Elsevier in Spanish Journal of Psychiatry and Mental Health
- Vol. 15 (4) , 281-286
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Amerindians may need clozapine dosing similar to that of AsiansRevista de Psiquiatría y Salud Mental, 2021
- All in OneJournal of Clinical Psychopharmacology, 2021
- Is there a Future for CYP1A2 Pharmacogenetics in the Optimal Dosing of Clozapine?Pharmacogenomics, 2020
- A Rational Use of Clozapine Based on Adverse Drug Reactions, Pharmacokinetics, and Clinical PharmacopsychologyPsychotherapy and Psychosomatics, 2020
- Around 3% of 1,300 Levels Were Elevated during Infections in a Retrospective Review of 131 Beijing Hospital In-Patients with More than 24,000 Days of Clozapine TreatmentPsychotherapy and Psychosomatics, 2020
- Future Studies on the Interaction Between Clozapine and Valproic Acid Should Aspire to Include Longitudinal Designs and Free Valproate Concentrations, and Should Consider that Inducer and/or Inhibitory Effects May Vary With Time, the Individual, and the Auto-Induction of Valproic AcidTherapeutic Drug Monitoring, 2020
- Rapid Titration and Decreased Clozapine Clearance May Help Explain Five Cases of Clozapine-Induced Myocarditis in a New York HospitalPsychosomatics, 2020
- Clinical determinants of fever in clozapine users and implications for treatment management: A narrative reviewSchizophrenia Research, 2019
- A comparative study of detection of myocarditis induced by clozapine: With and without cardiac monitoringPsychiatry Research, 2019
- A New Monitoring Protocol for Clozapine-Induced Myocarditis Based on an Analysis of 75 Cases and 94 ControlsAustralian & New Zealand Journal of Psychiatry, 2011